ASPIRE BIOPHARMA HOLDINGS INC (ASBP)
NASDAQHealth CareMedical - PharmaceuticalsSnapshot 2026-11-04
$6.93-5.13%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - PharmaceuticalsSnapshot 2026-11-04
QuarterlyIQ Insights · ASBP
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Model as of —
ASBP — legal / regulatory event — Changes in Registrant’s Certifying Accountant (a) Termination
Dated 2026-09-29
Changes in Registrant’s Certifying Accountant (a) Termination of Previous Independent Registered Accounting Firm On September 24, 2026 Turner Stone & Company, LLP ( “Turner” ) was dismissed by the Audit Committee of the Board of Directors of Aspire-Lakewood Holdings, Inc. (the “Company”) as the Company’s independent registered public accounting firm, effective as of that date. Turner’s report on the Company’s consolidated financial statements as of December 31, 2025 did not contain an adverse…
Why it matters: The board authorized repurchases but did not promise to complete them. Reported purchases would show the program is in use.
Supportive ifA filing says the company completed share purchases under the program. It gives the amount and share count.
Worry ifA later filing reports no purchases and says the program was paused or ended.
Why it matters: Aspire dismissed its auditor in September. A timely filing with no new audit issue would ease a key reporting concern.
Worry ifThe next company filing names the new audit firm and reports no delay or new audit concern.
Less concerning ifThe company reports a late filing, another auditor change, or a new audit issue.
Why it matters: DCSC added major sales and earnings to Aspire. The report can show whether that scale continues after the purchase.
Watch forThe Nov. 13 report shows DCSC revenue and adjusted EBITDA at or above the first-half 2026 pace of $103.9 million and $10.5 million.
Also watch forThe Nov. 13 report shows DCSC revenue or adjusted EBITDA below half of its first-half 2026 amount.
Why it matters: Aspire used a $22.5 million credit line and cash to fund the $30 million purchase. New figures can show the cash burden.
Worry ifThe Nov. 13 report shows the revolving credit balance rising above $22.5 million or cash falling from the level used at closing.
Less concerning ifThe report shows the credit balance at or below $22.5 million and cash at or above the closing level.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$308 on $10,000 · ±3.1% | How much price usually moves either way. |
| Bad day | $1,863 loss on $10,000 · 18.6% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,889 loss on $10,000 · 98.9% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.